Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of asunaprevir and daclatasvir on immune status in chronic HCV
2013-002991-42Phase 4Active
- Sponsor
- Foundation for Liver Research
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of asunaprevir and daclatasvir in hepatitis C virus infection, sponsored by Foundation for Liver Research. Primary endpoint: Sustained virologic response at 24 weeks post-treatment. Started Sep 2013; status: active.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2013-002991-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002991-42.